You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,626,870


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,626,870
Title: Stoppering method to maintain sterility
Abstract:A syringe assembly is provided which includes a hollow barrel that has an interior wall. The interior wall defines a chamber that retains medication. The hollow barrel also includes a distal end and a proximal end. The distal end of the hollow barrel has a passageway that is in contact with the chamber. The proximal end of the hollow barrel has an aperture. The syringe assembly also includes a primary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The primary plunger tip has a receptor to engage an engager of an elongated tip plunger rod. The syringe assembly also includes a secondary plunger tip that is slidably positioned, in fluid tight engagement, with the interior wall. The secondary plunger tip also has a receptor to engage an engager of a tip plunger rod. The secondary plunger tip is disposed between the primary plunger tip and the proximal end of the hollow barrel. The syringe assembly also includes a tip plunger rod, which facilitates operation of the secondary plunger tip, engaged to the secondary plunger tip. The present invention also provides a process for providing a lyophilized medication (i.e., lyophilizate) in a syringe assembly and also provides a process for reconstituting a medication in a syringe assembly.
Inventor(s): Yarborough; Cody L (Ft. Collins, CO), Duncan; Michael R. (Ft. Collins, CO), Norton; Richard L. (Ft. Collins, CO), Bawa; Rajan (Ft. Collins, CO), Madril; Dominic G. (Loveland, CO), Barrett; Christopher J. (Ft. Collins, CO)
Assignee: Artix Laboratories, Inc. (Fort Collins, CO)
Application Number:09/536,479
Patent Claim Types:
see list of patent claims
Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,626,870: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 6,626,870, titled "Stoppering method to maintain sterility," and provide a thorough analysis of its scope, claims, and the broader patent landscape.

Patent Overview

Patent Title and Abstract

United States Patent 6,626,870, issued on September 30, 2003, is titled "Stoppering method to maintain sterility." The patent describes a method and apparatus for stoppering containers, particularly those containing sterile or lyophilized substances, to maintain their sterility during the stoppering process[5].

Background of the Invention

The background section of the patent highlights the need for a method that ensures the sterility of containers, especially in the pharmaceutical and medical fields. Traditional methods often involved manual handling, which could compromise the sterility and safety of the contents.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are critical as they outline what is considered novel and non-obvious about the invention.

  • Claim 1: This claim describes the method of stoppering a container while maintaining sterility, involving the use of a stoppering device that prevents contamination during the process[5].

  • Claim 2: This claim details the apparatus used for stoppering, including a housing and a mechanism for inserting the stopper without compromising sterility[5].

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or variations of the invention.

  • Claim 3: This claim specifies the material of the stopper and the container, ensuring compatibility and maintaining sterility[5].

  • Claim 4: This claim describes the process of sterilizing the stoppering device before use[5].

Scope of the Invention

Patent Scope Metrics

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Research suggests that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

  • Claim Length: The claims in this patent are moderately detailed, ensuring clarity without being overly broad. This balance is crucial for maintaining patent quality and avoiding potential litigation issues.

  • Claim Count: The patent includes a manageable number of claims, which helps in defining the invention clearly without unnecessary complexity.

Breadth of Patent Classes

The patent falls under specific classes related to container stoppering and sterility maintenance. This classification helps in understanding the broader technological area and potential prior art.

Prior Art and Citation Analysis

Common Citation Document (CCD)

The Common Citation Document (CCD) consolidates prior art cited by multiple patent offices for the same invention. For this patent, reviewing the CCD would provide insights into similar inventions and how they have been treated by different patent offices[1].

Forward Citations

Forward citations indicate the impact of the patent on subsequent inventions. Analyzing these citations can reveal how the stoppering method has influenced other innovations in the field.

Patent Landscape

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This tool is useful for understanding the global reach and variations of the patented method[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can help identify if similar methods have been patented abroad[1].

Practical Applications

Pharmaceutical Industry

The method described in this patent is particularly relevant to the pharmaceutical industry, where maintaining sterility is paramount. Companies involved in the production of lyophilized drugs or other sterile products can benefit from this invention.

Medical Devices

The apparatus and method outlined in the patent can also be applied to medical devices that require sterile conditions, enhancing safety and compliance with regulatory standards.

Legal and Regulatory Considerations

Exclusivity and Patent Term

Understanding the exclusivity period and patent term is essential for determining the window of protection and potential licensing opportunities. The patent's expiration date and any exclusivity terms must be carefully reviewed[2].

Litigation and Licensing

The clarity and scope of the claims can impact the likelihood of litigation and the ease of licensing. Narrower, clearer claims tend to reduce the risk of disputes and facilitate smoother licensing processes[3].

Key Takeaways

  • Clear Claims: The patent's claims are moderately detailed, ensuring clarity and reducing the risk of litigation.
  • Sterility Maintenance: The method and apparatus are designed to maintain sterility, which is critical in pharmaceutical and medical applications.
  • Global Reach: The invention's impact can be assessed through global dossier services and international patent databases.
  • Practical Applications: The patent is highly relevant to the pharmaceutical industry and medical device manufacturers.
  • Legal Considerations: Understanding the exclusivity period, patent term, and claim scope is crucial for legal and regulatory compliance.

FAQs

Q: What is the main purpose of United States Patent 6,626,870?

A: The main purpose of this patent is to describe a method and apparatus for stoppering containers while maintaining their sterility, particularly relevant to the pharmaceutical and medical fields.

Q: How can the scope of this patent be measured?

A: The scope can be measured using metrics such as independent claim length and independent claim count, which help in assessing the clarity and breadth of the patent.

Q: What is the significance of the Common Citation Document (CCD) in patent analysis?

A: The CCD consolidates prior art cited by multiple patent offices, providing a comprehensive view of similar inventions and their treatment by different offices.

Q: How does this patent impact the pharmaceutical industry?

A: The patent provides a method to ensure the sterility of containers, which is crucial for the production of lyophilized drugs and other sterile products, enhancing safety and compliance.

Q: What are the legal considerations for this patent?

A: Understanding the exclusivity period, patent term, and claim scope is essential for determining the window of protection and potential licensing opportunities, as well as for legal and regulatory compliance.

Sources

  1. USPTO - How to Conduct a Preliminary U.S. Patent Search
  2. DrugPatentWatch - Approved Drug Products
  3. Hoover Institution - Patent Claims and Patent Scope
  4. Google Patents - US20030023203A1
  5. PubChem - US-6626870-B1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,626,870

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,626,870

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 285261 ⤷  Subscribe
Australia 2001249497 ⤷  Subscribe
Australia 4949701 ⤷  Subscribe
Canada 2404194 ⤷  Subscribe
Germany 60107935 ⤷  Subscribe
Denmark 1267965 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.